EDRH
ITRM

Edmond de Rothschild Holding’s Iterum Therapeutics ITRM Stock Holding History

Edmond de Rothschild Holding’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,666
Closed -$11K – 804
2022
Q3 		$11K Sell
6,666
-1
-0% -$3 ﹤0.01% 768
2022
Q2 		$20K Hold
6,667
– – ﹤0.01% 729
2022
Q1 		$36K Hold
6,667
– – ﹤0.01% 707
2021
Q4 		$39K Hold
6,667
– – ﹤0.01% 724
2021
Q3 		$56K Hold
6,667
– – ﹤0.01% 683
2021
Q2 		$231K Hold
6,667
– – 0.01% 515
2021
Q1 		$141K Buy
+6,667
New +$159K ﹤0.01% 521

Other funds holding ITRM

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Edmond de Rothschild Holding's ITRM Position: Q4 2022 in Review

Edmond de Rothschild Holding sold out of Iterum Therapeutics (ITRM) in Q4 2022, closing a stake of 6,666 shares — an estimated $11K sold.

Edmond de Rothschild Holding first reported a position in ITRM in Q1 2021 and held it in 7 quarters. The position peaked at $231K in Q2 2021. 23 funds tracked by Wall St. Rank hold ITRM as of Q4 2022.

  • Edmond de Rothschild Holding reported no remaining Iterum Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 6,666 Iterum Therapeutics shares in Q4 2022, an estimated $11K.
  • Edmond de Rothschild Holding first reported a position in Iterum Therapeutics in Q1 2021 and held it in 7 quarters.
  • Edmond de Rothschild Holding's Iterum Therapeutics position peaked at $231K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q4 2022.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2022, filed 9 Feb 2023.